Absolute oxygen tension (pO2) muscle tissue as determined by in murine fatty and EPR

被引:74
作者
Matsumoto, A
Matsumoto, S
Sowers, AL
Koscielniak, JW
Trigg, NJ
Kuppusamy, P
Mitchell, JB
Subramanian, S
Krishna, MC
Matsumoto, K
机构
[1] NCI, Radiat Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[2] NCI, Ctr Canc Res, Lab Proteom & Analyt Technol, Frederick, MD USA
[3] Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA
关键词
electron paramagnetic resonance; oxygen concentration; spin probe; lithium phthalocyanine; mouse; mammary gland; skeletal muscle;
D O I
10.1002/mrm.20714
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 [临床医学]; 100207 [影像医学与核医学]; 1009 [特种医学];
摘要
The absolute partial pressure of oxygen (pO(2)) in the mammary gland pad and femoral muscle of female mice was measured using EPR oximetry at 700 MHz. A small quantity of lithium phthalocyanine (LiPc) crystals was implanted in both mammary and femoral muscle tissue of female C3H mice. Subsequent EPR measurements were carried out 1-30 days after implantation with or without control of core body temperature. The pO(2) values in the tissue became stable 2 weeks after implantation of LiPc crystals. The pO(2) level was found to be higher in the femoral muscle than in the mammary tissue. However, the pO(2) values showed a strong dependence on the core body temperature of the mice. The pO(2) values were responsive to carbogen (95% O-2 5% CO2) breathing even 44-58 days after the implantation of LiPc. The LiPc linewidth was also sensitive to changes in the blood supply even 60 days after implantation of the crystals. This study further validates the use of LiPc crystals and EPR oximetry for long-term non-invasive assessment of pO(2) levels in tissues, underscores the importance of maintaining normal body core temperature during the measurements, and demonstrates that mammary tissue functions at a lower pO(2) level than muscle in female C3H mice.
引用
收藏
页码:1530 / 1535
页数:6
相关论文
共 36 条
[1]
Preparation and EPR studies of lithium phthalocyanine radical as an oxymetric probe [J].
Afeworki, M ;
Miller, NR ;
Devasahayam, N ;
Cook, J ;
Mitchell, JB ;
Subramanian, S ;
Krishna, MC .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 25 (01) :72-78
[2]
Optimizing the use of combined radioimmunotherapy and hypoxic cytotoxin therapy as a function of tumor hypoxia [J].
Blumenthal, RD ;
Taylor, A ;
Osorio, L ;
Ochakovskaya, R ;
Raleigh, JA ;
Papadopoulou, M ;
Bloomer, WD ;
Goldenberg, DM .
INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (04) :564-571
[3]
Changes in oxygenation of intracranial tumors with carbogen: a BOLD MRI and EPR oximetry study [J].
Dunn, JF ;
O'Hara, JA ;
Zaim-Wadghiri, Y ;
Lei, H ;
Meyerand, ME ;
Grinberg, OY ;
Hou, HG ;
Hoopes, PJ ;
Demidenko, E ;
Swartz, HM .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2002, 16 (05) :511-521
[4]
Oxygenation predicts radiation response and survival in patients with cervix cancer [J].
Fyles, AW ;
Milosevic, M ;
Wong, R ;
Kavanagh, MC ;
Pintilie, M ;
Sun, A ;
Chapman, W ;
Levin, W ;
Manchul, L ;
Keane, TJ ;
Hill, RP .
RADIOTHERAPY AND ONCOLOGY, 1998, 48 (02) :149-156
[5]
Small particles of fusinite and carbohydrate chars coated with aqueous soluble polymers:: Preparation and applications for in vivo EPR oximetry [J].
Gallez, B ;
Debuyst, R ;
Dejehet, F ;
Liu, KJ ;
Walczak, T ;
Goda, F ;
Demeure, R ;
Taper, H ;
Swartz, HM .
MAGNETIC RESONANCE IN MEDICINE, 1998, 40 (01) :152-159
[6]
INVIVO OXIMETRY USING A NITROXIDE-LIPOSOME SYSTEM [J].
GLOCKNER, JF ;
CHAN, HC ;
SWARTZ, HM .
MAGNETIC RESONANCE IN MEDICINE, 1991, 20 (01) :123-133
[7]
IN-VIVO OXIMETRY USING EPR AND INDIA INK [J].
GODA, F ;
LIU, KJ ;
WALCZAK, T ;
OHARA, JA ;
JIANG, JJ ;
SWARTZ, HM .
MAGNETIC RESONANCE IN MEDICINE, 1995, 33 (02) :237-245
[8]
Effects of hyperbaric oxygen and normobaric carbogen on the radiation response of the rat rhabdomyosarcoma R1H [J].
Hartmann, KA ;
van der Kleij, AJ ;
Carl, UM ;
Hulshof, MCCM ;
Willers, R ;
Sminia, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :1037-1044
[9]
Hockel M, 1996, CANCER RES, V56, P4509
[10]
Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen [J].
Horsman, MR ;
Overgaard, J .
RADIOTHERAPY AND ONCOLOGY, 2004, 70 (03) :301-309